Co-Authors
This is a "connection" page, showing publications co-authored by Cheng-Bin Wang and Giuseppe Lippi.
Connection Strength
1.454
-
Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations. Clin Chem Lab Med. 2020 06 25; 58(7):1053-1062.
Score: 0.889
-
IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection. Clin Chem Lab Med. 2020 10 07; 58(12):1993-2000.
Score: 0.227
-
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals. Clin Chem Lab Med. 2021 08 26; 59(9):1507-1515.
Score: 0.059
-
IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2. Clin Chem Lab Med. 2020 10 07; 58(12):2001-2008.
Score: 0.057
-
IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients. Clin Chem Lab Med. 2020 10 07; 58(12):2009-2016.
Score: 0.057
-
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med. 2020 06 25; 58(7):1037-1052.
Score: 0.056
-
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey. Clin Chem Lab Med. 2020 08 27; 58(9):1441-1449.
Score: 0.055
-
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey. Clin Chem Lab Med. 2020 08 27; 58(9):1433-1440.
Score: 0.055